PMID- 12547829 OWN - NLM STAT- MEDLINE DCOM- 20030519 LR - 20210209 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 278 IP - 14 DP - 2003 Apr 4 TI - Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry. PG - 11909-15 AB - Store-operated cation (SOC) channels and capacitative Ca(2+) entry (CCE) play very important role in cellular function, but the mechanism of their activation remains one of the most intriguing and long lasting mysteries in the field of Ca(2+) signaling. Here, we present the first evidence that Ca(2+)-independent phospholipase A(2) (iPLA(2)) is a crucial molecular determinant in activation of SOC channels and store-operated Ca(2+) entry pathway. Using molecular, imaging, and electrophysiological techniques, we show that directed molecular or pharmacological impairment of the functional activity of iPLA(2) leads to irreversible inhibition of CCE mediated by nonselective SOC channels and by Ca(2+)-release-activated Ca(2+) (CRAC) channels. Transfection of vascular smooth muscle cells (SMC) with antisense, but not sense, oligonucleotides for iPLA(2) impaired thapsigargin (TG)-induced activation of iPLA(2) and TG-induced Ca(2+) and Mn(2+) influx. Identical inhibition of TG-induced Ca(2+) and Mn(2+) influx (but not Ca(2+) release) was observed in SMC, human platelets, and Jurkat T-lymphocytes when functional activity of iPLA(2) was inhibited by its mechanism-based suicidal substrate, bromoenol lactone (BEL). Moreover, irreversible inhibition of iPLA(2) impaired TG-induced activation of single nonselective SOC channels in SMC and BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid)-induced activation of whole-cell CRAC current in rat basophilic leukemia cells. Thus, functional iPLA(2) is required for activation of store-operated channels and capacitative Ca(2+) influx in wide variety of cell types. FAU - Smani, Tarik AU - Smani T AD - Boston University School of Medicine, Boston, Massachusetts 02118, USA. FAU - Zakharov, Sergey I AU - Zakharov SI FAU - Leno, Endri AU - Leno E FAU - Csutora, Peter AU - Csutora P FAU - Trepakova, Elena S AU - Trepakova ES FAU - Bolotina, Victoria M AU - Bolotina VM LA - eng GR - HL54150/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20030123 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Calcium Channels) RN - 0 (Naphthalenes) RN - 0 (Oligonucleotides, Antisense) RN - 0 (Phosphodiesterase Inhibitors) RN - 0 (Pyrones) RN - 42Z2K6ZL8P (Manganese) RN - 88070-98-8 (6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one) RN - EC 3.1.1.32 (Phospholipases A) RN - EC 3.1.1.4 (Group VI Phospholipases A2) RN - EC 3.1.1.4 (PLA2G6 protein, human) RN - EC 3.1.1.4 (Phospholipases A2) RN - EC 3.1.1.4 (Pla2g6 protein, mouse) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Aorta/cytology MH - Blood Platelets/cytology/*enzymology MH - Calcium/*metabolism MH - Calcium Channels/*metabolism MH - Group VI Phospholipases A2 MH - Humans MH - Jurkat Cells MH - Manganese/pharmacokinetics MH - Membrane Potentials/drug effects/physiology MH - Mice MH - Myocytes, Smooth Muscle/cytology/*enzymology MH - Naphthalenes/pharmacology MH - Oligonucleotides, Antisense/pharmacology MH - Patch-Clamp Techniques MH - Phosphodiesterase Inhibitors/pharmacology MH - Phospholipases A/genetics/*metabolism MH - Phospholipases A2 MH - Pyrones/pharmacology MH - Rabbits MH - Rats EDAT- 2003/01/28 04:00 MHDA- 2003/05/20 05:00 CRDT- 2003/01/28 04:00 PHST- 2003/01/28 04:00 [pubmed] PHST- 2003/05/20 05:00 [medline] PHST- 2003/01/28 04:00 [entrez] AID - S0021-9258(19)64774-5 [pii] AID - 10.1074/jbc.M210878200 [doi] PST - ppublish SO - J Biol Chem. 2003 Apr 4;278(14):11909-15. doi: 10.1074/jbc.M210878200. Epub 2003 Jan 23.